About TK2d Companion

It’s well documented that people with rare diseases are as underserved informationally as they are therapeutically. This is particularly true with ultra-rare diseases like thymidine kinase 2 deficiency (TK2d), with families often searching in vain for answers to their questions, or finding news and perspectives that are written for doctors, researchers, and investors — but not for patients and caregivers.

TK2d Companion is part of Haymarket Media’s Rare Disease Companion network of websites, which fills the wide informational gaps that exist for rare disease patient communities on the web. TK2d Companion provides families with news, educational materials, and trustworthy insights that give them the answers and support that they are looking for.

The editorial team at TK2d Companion:

  • Publishes news and educational articles about the science, research, and therapeutic advancements for treating TK2d in a style that patients and families can easily understand.
  • Works directly with parents and caregivers who have direct knowledge and expertise about TK2d, having experienced it firsthand, ensuring that our articles are accurate and appropriate for the TK2d community.
  • Tells powerful and exclusive stories about women and their children who have persevered through the challenges and difficulties of TK2d.
  • Offers insights into the TK2d patient journey and how others have navigated every facet of the TK2d diagnosis.

All Rare Disease Companion websites offer readers industry-leading accessibility features that make it easier for people with rare diseases and disabilities to read and navigate the website. Haymarket Media is committed to serving the needs of the rare disease community — please contact a member of our staff if you encounter any accessibility issues on the website.

Haymarket Media also supports healthcare providers and the care teams who treat mothers and babies with TK2d at Rare Disease Advisor (RDA). Be sure to visit RDA’s TK2d Junction for exclusive news, resources, and perspectives geared toward the HCP community.